Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024866 · ClinicalTrials.gov registry record
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
A clinical trial of Nonmelanoma Skin Cancer, sponsored by Xoft.
- Completed
- Registry status
- 369
- Enrollment target
- 4
- Study locations
NCT03024866 is a study of Nonmelanoma Skin Cancer that has completed, run by Xoft. The registered enrollment target is 369 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT03024866, a study of Nonmelanoma Skin Cancer, has completed, sponsored by Xoft.
- COMPLETED
- Registry status
- 369 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.
Conditions Studied
Interventions
- PROCEDURE Electronic Brachytherapy
Study Locations (4)
California
- Kenneth A. Miller, PC - Los Gatos
- Dermatology & Laser Center of San Diego - San Diego
- Dermatology and Laser Center of San Diego - San Diego
Nevada
- Strimling Laser and Vein Institute - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024866
The ClinicalTrials.gov registry entry for NCT03024866 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xoft, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nonmelanoma Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Electronic Brachytherapy is the first listed.
NCT03024866 reports 4 study locations spanning 2 distinct geographic areas - top geographies include California, Nevada.
Frequently Asked Questions
What is clinical trial NCT03024866 about?
NCT03024866 is a clinical study titled "Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.". This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term...
What is the current status of trial NCT03024866?
This trial is currently completed. The enrollment target is 369 participants. The study started on 2016-10. Estimated completion is 2017-03.
What conditions does trial NCT03024866 study?
This clinical trial studies the following conditions: Nonmelanoma Skin Cancer.
What interventions are being tested in trial NCT03024866?
The interventions under investigation include: Electronic Brachytherapy (PROCEDURE).
Who is sponsoring clinical trial NCT03024866?
This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03024866 being conducted?
This trial has 4 study locations across California, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonmelanoma Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.